Add another Item to this comparison
Add Item
Basic Information |
Generic Name |
|
Methamphetamine |
vs |
Dextroamphetamine |
|
Class |
|
Anorexiants, Cns Stimulants |
vs |
Cns Stimulants |
|
Prescription Generic Available |
|
Yes |
vs |
Yes |
|
Pregnancy cat. |
|
C(us) |
vs |
B3(au) C(us) |
|
Approved Age |
|
6 And Older |
vs |
6 And Older |
|
Legal Status |
|
Schedule Ii (us) |
vs |
Controlled (s8)(au)
Schedule I(ca) Class B(uk) Schedule Ii(us) |
|
Dependence Liability |
|
High |
vs |
High |
|
Excretion |
|
Renal |
vs |
Urinary |
|
Possible Side Effects |
|
Some Loss Of Appetite, Weight, Dry Mouth, Headache, Sleep Problems, Irritability, Agitation, Anxiety, Addiction |
vs |
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
Dosage, Usage and Forms |
Routes (of administration) |
|
Ingestion, Intravenous, Insufflation, Inhalation, Suppository |
vs |
Oral, Insufflation, Rectal, Sublingual |
|
Dosage |
|
5 Mg Q Am–10 Mg Bid |
vs |
|
|
Maximum daily dose |
|
10 mg |
vs |
|
|
Duration |
|
Short-acting |
vs |
Short-acting |
|
Duration - time |
|
3-5 H |
vs |
4-6 H |
|
Chemical Data |
Molecular mass (g/mol) |
|
149.2337 G/mol |
vs |
135.21 G/mol |
|
Half Life |
|
9-12 Hours |
vs |
4-6 Hrs |
|
Formula |
|
C10h15n |
vs |
C9h13n |
|
Bioavailability |
|
62.7% Oral; 79% Nasal; 90.3% Smoked; 99% Rectally; 100% Iv |
vs |
75% (oral) |
|
Protein binding |
|
|
vs |
15 % |
|
Metabolism |
|
Hepatic |
vs |
Hepatic |
|
Compare Desoxyn vs Dexedrine ADHD Medications
cancel